Protara Therapeutics, Inc.

TARA

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001359931

SEC filings (opens in a new tab)

No open-market purchases or sales by Protara Therapeutics, Inc. insiders were filed in the last 90 days; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Protara Therapeutics, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025 All holders in Q3 2025

13F holders of TARA: Q3 2025 compared with Q4 2025
Measure	Q3 2025	Of which not filed for Q4 2025	Q4 2025	Change
Holders	81	1	105	+25
Shares	26.2M	11.6K	39.8M	+13.6M (+52.0%)
Value	$114.0M	$51.3K	$212.3M	+$98.3M (+86.3%)

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (32)

Institutions that held Protara Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to TARA in Q4 2025
Institution	Shares	Value	% of portfolio
Sio Capital Management, LLC	1,715,394	$9.14M	1.52%
Adage Capital Partners GP, L.L.C.	1,043,478	$5.56M	0.01%
Maven Securities LTD	754,626	$4.02M	0.51%
Sphera Funds Management Ltd.	650,000	$3.46M	0.72%
Burkehill Global Management, LP	450,000	$2.40M	0.16%
Alyeska Investment Group, L.P.	350,000	$1.87M	0.01%
Ameriprise Financial Inc	153,985	$820.7K	0.00%
Walleye Capital LLC	145,876	$777.5K	0.00%
Monashee Investment Management LLC	125,000	$666.3K	0.38%
XTX Topco Ltd	115,363	$614.9K	0.02%
Qube Research & Technologies Ltd	114,331	$609.4K	0.00%
EAM Investors, LLC	103,611	$552.2K	0.06%
Virtu Financial LLC	68,956	$368.0K	0.01%
SEI Investments Co	63,079	$336.2K	0.00%
Panagora Asset Management Inc	43,796	$233.4K	0.00%
Alps Advisors Inc	42,389	$225.9K	0.00%
HRT Financial LP	36,260	$193.0K	0.00%
Nano Cap New Millennium Growth Fund L P	35,000	$186.6K	0.16%
Longaeva Partners L.P.	33,857	$180.5K	0.02%
Point72 Asset Management, L.P.	28,107	$149.8K	0.00%
Deutsche Bank AG	25,096	$133.8K	0.00%
Engineers Gate Manager LP	21,886	$116.7K	0.00%
Campbell & CO Investment Adviser LLC	20,551	$109.5K	0.01%
Scientech Research LLC	17,215	$91.8K	0.06%
AQR Capital Management LLC	14,681	$78.3K	0.00%
Empery Asset Management, LP	12,832	$68.4K	0.06%
Manufacturers Life Insurance Company, The	11,084	$59.1K	0.00%
Axq Capital, LP	10,815	$57.6K	0.01%
Persistent Asset Partners Ltd	10,733	$57.2K	0.03%
MetLife Investment Management	4,399	$23.4K	0.00%
Northwestern Mutual Wealth Management Co	2	$11	0.00%
Rothschild Investment LLC	1	$5	0.00%

Sold out (7)

Institutions that held Protara Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of TARA in Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
StemPoint Capital LP	363,666	$1.58M
J. Goldman & Co LP	100,350	$436.5K
Prelude Capital Management, LLC	21,516	$93.6K
Simplex Trading, LLC	17,890	$77.0K
Los Angeles Capital Management LLC	15,545	$67.6K
Advisory Services Network, LLC	1,000	$4.35K
SRS Capital Advisors, Inc.	48	$209

Not filed for Q4 2025 yet (1)

Institutions that held Protara Therapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TARA in Q3 2025 that haven't filed for Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Wolverine Trading, LLC	11,636	$51.3K